The CuO doped with 5%20% Mn（molar fraction） solids were sintered from CuO and MnO2 powder at high temperature （1 273 K） for 8 h. X-ray diffraction was used to determine the solid crystallinity and to address the f...The CuO doped with 5%20% Mn（molar fraction） solids were sintered from CuO and MnO2 powder at high temperature （1 273 K） for 8 h. X-ray diffraction was used to determine the solid crystallinity and to address the formation of secondary phases. It is found that it is difficult to achieve pure Cu1-xMnxO phase using standard solid phase reaction. However, sintering under a pressure of 27.7 MPa significantly reduces the undesirable second phase CuMn2O4, providing a route to achieve pure Cu1-xMnxO phase. SQUID magnetometry was employed to characterize the magnetic properties. Mn-doped CuO presents ferromagnetic characteristics below 70 K. Electrical transport properties were measured in a current-perpendicular-to-plane（CPP） geometry using the PPMS, which suggests variable-range hopping mechanism.展开更多
The solid forms of drugs play a central role in controlling their physicochemical properties and consequently the bioavailability. Multiple types of drug solid forms have been developed to achieve the desirable pharma...The solid forms of drugs play a central role in controlling their physicochemical properties and consequently the bioavailability. Multiple types of drug solid forms have been developed to achieve the desirable pharmaceutical profiles, but new solid forms will provide more options for the solid-state property optimization and hence are highly desirable. This review focuses on a new pharmaceutical solid form, drug-polymer inclusion complexes （ICs）, and summarizes their structural features, structure- property relationships, as well as potential pharmaceutical applications展开更多
基金Projects(50472092 50325209 50232030) supported by the National Natural Science Foundations of China
文摘The CuO doped with 5%20% Mn（molar fraction） solids were sintered from CuO and MnO2 powder at high temperature （1 273 K） for 8 h. X-ray diffraction was used to determine the solid crystallinity and to address the formation of secondary phases. It is found that it is difficult to achieve pure Cu1-xMnxO phase using standard solid phase reaction. However, sintering under a pressure of 27.7 MPa significantly reduces the undesirable second phase CuMn2O4, providing a route to achieve pure Cu1-xMnxO phase. SQUID magnetometry was employed to characterize the magnetic properties. Mn-doped CuO presents ferromagnetic characteristics below 70 K. Electrical transport properties were measured in a current-perpendicular-to-plane（CPP） geometry using the PPMS, which suggests variable-range hopping mechanism.
基金supported by the National Natural Science Foundation of China (No. 21434008)
文摘The solid forms of drugs play a central role in controlling their physicochemical properties and consequently the bioavailability. Multiple types of drug solid forms have been developed to achieve the desirable pharmaceutical profiles, but new solid forms will provide more options for the solid-state property optimization and hence are highly desirable. This review focuses on a new pharmaceutical solid form, drug-polymer inclusion complexes （ICs）, and summarizes their structural features, structure- property relationships, as well as potential pharmaceutical applications
